Healthcare >> CEO Interviews >> September 13, 2002

Lloyd Segal – Caprion Pharmaceuticals Inc

TWST: Could you give us a brief overview of Caprion Pharmaceutical?

Mr. Segal: Caprion applies CellCarta, our proprietary technology in sub-

cellular proteomics, for the discovery of new drugs